A novel fixed-combination timolol-netarsudil-latanoprost ophthalmic solution for the treatment of glaucoma and ocular hypertension

Currently commercial fixed-concomitant three agents have multiple problems such as multiple dosing administration, poor efficacy and side effects. Once-daily fixed-combination timolol-netarsudil-latanoprost ophthalmic solution (FC-TNL) has the ability to treat glaucoma by lowering the intraocular pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Tao, Zhang, Yunran, Chi, Meiling, Zhao, Chen, Cao, Linlin, Tian, Chutong, Kamei, K., Zheng, Ying, Jiang, Qikun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shenyang Pharmaceutical University 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800952/
https://www.ncbi.nlm.nih.gov/pubmed/36600899
http://dx.doi.org/10.1016/j.ajps.2022.11.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800952/
https://www.ncbi.nlm.nih.gov/pubmed/36600899
http://dx.doi.org/10.1016/j.ajps.2022.11.001

Ejemplares similares